Teladoc Health annual operating margin
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Teladoc Health's operating margin was −10.39% for fiscal 2025.
View full Teladoc Health company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −10.39% | +29.34 pp |
| 2024 | 2024-12-31 | −39.73% | −30.18 pp |
| 2023 | 2023-12-31 | −9.55% | +557.72 pp |
| 2022 | 2022-12-31 | −567.27% | −554.20 pp |
| 2021 | 2021-12-31 | −13.07% | +33.22 pp |
| 2020 | 2020-12-31 | −46.29% | −31.75 pp |
| 2019 | 2019-12-31 | −14.54% | +2.42 pp |
| 2018 | 2018-12-31 | −16.95% | +15.36 pp |
| 2017 | 2017-12-31 | −32.32% | +18.56 pp |
| 2016 | 2016-12-31 | −50.88% | +21.21 pp |
| 2015 | 2015-12-31 | −72.09% | −37.28 pp |
| 2014 | 2014-12-31 | −34.81% | −5.32 pp |
| 2013 | 2013-12-31 | −29.48% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −6.11% | +2.50 pp |
| Q1 2026 | 2026-03-31 | −10.06% | +9.10 pp |
| Q4 2025 | 2025-12-31 | −5.60% | +1.92 pp |
| Q3 2025 | 2025-09-30 | −8.29% | −1.36 pp |
| Q2 2025 | 2025-06-30 | −8.61% | +122.32 pp |
| Q1 2025 | 2025-03-31 | −19.16% | −5.68 pp |
| Q4 2024 | 2024-12-31 | −7.53% | −2.22 pp |
| Q3 2024 | 2024-09-30 | −6.93% | +2.87 pp |
| Q2 2024 | 2024-06-30 | −130.93% | −119.95 pp |
| Q1 2024 | 2024-03-31 | −13.48% | −1.23 pp |
| Q4 2023 | 2023-12-31 | −5.31% | +593.01 pp |
| Q3 2023 | 2023-09-30 | −9.80% | +1.93 pp |
| Q2 2023 | 2023-06-30 | −10.98% | +511.75 pp |
| Q1 2023 | 2023-03-31 | −12.25% | +1167.44 pp |
| Q4 2022 | 2022-12-31 | −598.32% | −590.85 pp |
| Q3 2022 | 2022-09-30 | −11.73% | −0.12 pp |
| Q2 2022 | 2022-06-30 | −522.73% | −507.04 pp |
| Q1 2022 | 2022-03-31 | −1,179.69% | −1161.03 pp |
| Q4 2021 | 2021-12-31 | −7.47% | +112.14 pp |
| Q3 2021 | 2021-09-30 | −11.61% | −4.78 pp |
| Q2 2021 | 2021-06-30 | −15.69% | −12.71 pp |
| Q1 2021 | 2021-03-31 | −18.66% | −7.04 pp |
| Q4 2020 | 2020-12-31 | −119.61% | −109.65 pp |
| Q3 2020 | 2020-09-30 | −6.83% | +7.63 pp |
| Q2 2020 | 2020-06-30 | −2.98% | +13.93 pp |
| Q1 2020 | 2020-03-31 | −11.62% | +6.18 pp |
| Q4 2019 | 2019-12-31 | −9.96% | +4.57 pp |
| Q3 2019 | 2019-09-30 | −14.46% | −0.24 pp |
| Q2 2019 | 2019-06-30 | −16.90% | +2.29 pp |
| Q1 2019 | 2019-03-31 | −17.80% | +3.50 pp |
| Q4 2018 | 2018-12-31 | −14.53% | +17.30 pp |
| Q3 2018 | 2018-09-30 | −14.22% | +17.16 pp |
| Q2 2018 | 2018-06-30 | −19.19% | +13.31 pp |
| Q1 2018 | 2018-03-31 | −21.30% | +13.21 pp |
| Q4 2017 | 2017-12-31 | −31.84% | +3.54 pp |
| Q3 2017 | 2017-09-30 | −31.38% | +31.18 pp |
| Q2 2017 | 2017-06-30 | −32.50% | +22.10 pp |
| Q1 2017 | 2017-03-31 | −34.51% | +20.22 pp |
| Q4 2016 | 2016-12-31 | −35.37% | +27.99 pp |
| Q3 2016 | 2016-09-30 | −62.56% | +0.50 pp |
| Q2 2016 | 2016-06-30 | −54.60% | +34.29 pp |
| Q1 2016 | 2016-03-31 | −54.73% | +21.65 pp |
| Q4 2015 | 2015-12-31 | −63.37% | −28.00 pp |
| Q3 2015 | 2015-09-30 | −63.06% | −35.28 pp |
| Q2 2015 | 2015-06-30 | −88.89% | — |
| Q1 2015 | 2015-03-31 | −76.38% | — |
| Q3 2014 | 2014-09-30 | −35.37% | — |
| Q2 2014 | 2014-06-30 | −27.78% | — |
Over the last five reported fiscal years, Teladoc Health's operating margin increased from −46.29% to −10.39%, a change of +35.90 percentage points. The latest reported quarter, Q2 2026, shows −6.11%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Teladoc Health filings at SEC.gov ↗